Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Jan;39(1):217-224.
doi: 10.1007/s00345-020-03160-9. Epub 2020 Mar 21.

Radiation exposure during retrograde intrarenal surgery (RIRS): a prospective multicenter evaluation

Affiliations
Multicenter Study

Radiation exposure during retrograde intrarenal surgery (RIRS): a prospective multicenter evaluation

Simon Hein et al. World J Urol. 2021 Jan.

Abstract

Purpose: Retrograde intrarenal surgery (RIRS) may require extensive X-ray usage. We evaluated the impact of preoperative surgeon briefing regarding the inclusion and evaluation of fluoroscopy time (FT) and dose area product (DAP) in a multicenter study on the applied X-ray usage.

Methods: A prospective multicenter study of 6 tertiary centers was performed. Each center recruited up to 25 prospective patients with renal stones of any size for RIRS. Prior to study´s onset, all surgeons were briefed about hazards of radiation and on strategies to avoid high doses in RIRS. Prospective procedures were compared to past procedures, as baseline data. FT was defined as the primary outcome. Secondary parameters were stone-free rate (SFR), complications according to the Clavien, SATAVA and postureteroscopic lesion scale. Results were analyzed using T test, chi-squared test, univariate analysis and confirmed in a multivariate regression model.

Results: 303 patients were included (145 retro- and 158 prospective). Mean FT and DAP were reduced from 130.8 s/565.8 to 77.4 s/357.8 (p < 0.05). SFR was improved from 85.5% to 93% (p < 0.05). Complications did not vary significantly. Neither stone position (p = 0.569), prestenting (p = 0.419), nor surgeons' experience (> 100 RIRS) had a significant impact on FT. Significant univariate parameters were confirmed in a multivariate model, revealing X-ray training to be radiation protective (OR - 44, p = 0.001).

Conclusions: Increased surgeon awareness of X-ray exposure risks has a significant impact on FT and DAP. This "awareness effect" is a simple method to reduce radiation exposure for the patient and OR staff without the procedures´ outcome and safety being affected.

Keywords: Flexible ureteroscopy; Fluoroscopy; Ionizing radiation exposure; Nephrolithiasis; Urolithiasis; X-ray exposure.

PubMed Disclaimer

Conflict of interest statement

Simon Hein: German Federal Ministry of Education and Research, Berlin, GER—research funding Germany (unrelated to the present work). Rodrigo Suarez-Ibarrola: German Federal Ministry of Education and Research, Berlin, GER—research funding Germany (unrelated to the present work). Martin Schoenthaler: consultant contracts with NeoTract Inc., Pleasanton, USA and Trokamed GmbH, Geisingen, Germany (unrelated to the present work). Arkadiusz Miernik: German Federal Ministry of Education and Research, Berlin, GER—research funding, German Association of Urology, Düsseldorf, GER—travel sponsoring, European Association of Urology, Arnhem, NL—travel sponsoring, Walter de Gruyter, Berlin, GER—royalties, RichardWolf GmbH, Knittlingen, GER—speaker’s fee, KLS Martin, Tuttlingen, GER—advisor, Avatera medical, Jena, GER—advisor, Lisa laser OHG, GER—proctor, Schoelly fiberoptics GmbH, GER—advisor, Optimed GmbH, Ettlingen, GER—advisor (unrelated to the present work). Andreas Neisius: Boston Scientific GmbH, Ratingen, GER, consultant, Karl Storz GmbH, Tuttlingen, GER consultant, Richard Wolf GmbH, Knittlingen, GER, travel grants, advisor, Optimed GmbH, Ettlingen, GER, advisor (unrelated to the present work). Marco Schnabel: Advisory board Ipsen. Financial support as guest speaker: Janssen, Bristol-Myers-Squibb, Novartis, medac, Bayer, Roche, Dornier (all unrelated to the present work).

Figures

Fig. 1
Fig. 1
Radar chart, primary and secondary outcomes

References

    1. Chen TT, Wang C, Ferrandino MN, Scales CD, Yoshizumi TT, Preminger GM, Lipkin ME. Radiation exposure during the evaluation and management of nephrolithiasis. J Urol. 2015;194(4):878–885. doi: 10.1016/j.juro.2015.04.118. - DOI - PubMed
    1. Turk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2015) EAU guidelines on urolithiasis 2015. https://uroweb.org/guideline/urolithiasis/
    1. Oberlin DT, Flum AS, Bachrach L, Matulewicz RS, Flury SC. Contemporary surgical trends in the management of upper tract calculi. J Urol. 2015;193(3):880–884. doi: 10.1016/j.juro.2014.09.006. - DOI - PubMed
    1. Lipkin ME, Wang AJ, Toncheva G, Ferrandino MN, Yoshizumi TT, Preminger GM. Determination of patient radiation dose during ureteroscopic treatment of urolithiasis using a validated model. J Urol. 2012;187(3):920–924. doi: 10.1016/j.juro.2011.10.159. - DOI - PubMed
    1. Scott BR. Stochastic thresholds: a novel explanation of nonlinear dose-response relationships for stochastic radiobiological effects. Dose-response Publ Int Hormesis Soc. 2006;3(4):547–567. doi: 10.2203/dose-response.003.04.009. - DOI - PMC - PubMed

Publication types

LinkOut - more resources